| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65219-200-05 | 65219-200 | HUMAN PRESCRIPTION DRUG | Temsirolimus | Temsirolimus | KIT | INTRAVENOUS | 20201120 | N/A | ANDA | ANDA207383 | Fresenius Kabi USA, LLC | 1 KIT in 1 KIT (65219-200-05) * 1 mL in 1 VIAL, SINGLE-DOSE (65219-205-05) * 1.8 mL in 1 VIAL, SINGLE-DOSE (65219-202-05) | ||
| 68083-202-01 | 68083-202 | HUMAN PRESCRIPTION DRUG | Temsirolimus | Temsirolimus Injection | KIT | 20190826 | N/A | ANDA | ANDA207383 | Gland Pharma Limited | 1 KIT in 1 CARTON (68083-202-01) * 1 mL in 1 VIAL, SINGLE-USE (68083-200-01) * 1.8 mL in 1 VIAL, SINGLE-USE (68083-201-01) | |||
| 72611-785-02 | 72611-785 | HUMAN PRESCRIPTION DRUG | Temsirolimus | Temsirolimus Injection | KIT | 20200508 | N/A | ANDA | ANDA207383 | Almaject, Inc. | 1 KIT in 1 CARTON (72611-785-02) * 1 mL in 1 VIAL, SINGLE-DOSE (72611-780-01) * 1.8 mL in 1 VIAL, SINGLE-DOSE (72611-782-01) |